| abstract |
The present invention relates to a composition for treating, ameliorating or preventing obesity comprising an extract of Ganoderma lucidum as an active ingredient. In particular, the active ingredient of the present invention, gutralyx extract, can effectively inhibit adipocyte differentiation of adipocyte precursor cells and fat production of adipocytes, and thus is excellent in the treatment, improvement and prevention of obesity, , Since it is derived from natural materials, it has no side effects and can be widely used for the treatment, improvement or prevention of obesity. |